Development of a novel small molecule-based approach for accelerated fracture repair in the aging skeleton
Ended Project Grant Awarded Last action
- Award ID
- R44AR076882
- Recipient
-
Cayman Chemical Co Inc. UEI T1ZHJRGR7TF4
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,478,369
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date
- Originally
- Place of performance
- Ann Arbor, MI 48108, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $750,058 | |
| Original award | $728,311 |
Quick answers
Who received award R44AR076882?
R44AR076882 was awarded to Cayman Chemical Co Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 13, 2019.
How much is award R44AR076882 worth?
$1,478,369 has been obligated on R44AR076882.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award